Iloprost Affects Macrophage Activation and CCL2 Concentrations in a Microdialysis Model in Rats.

Purpose: The hypothesis that locally-released iloprost, a synthetic prostacyclin analog, affects macrophage phenotype at a microdialysis implant in the subcutaneous space of rats was tested. Macrophage activation towards alternatively-activated phenotypes using pharmaceutical release is of interest to improve integration of implants and direct the foreign body reaction toward a successful outcome.

Methods: Macrophage cell culture was used to test iloprost macrophage activation in vitro.